by Jason Farmer | Jun 20, 2026 | Financial Oversight
Private equity buyers pay premiums specifically for OB/GYN practices with integrated ancillary services. That premium exists because the services generate real margin – but each one carries compliance requirements that are not optional and not uniform across...
by Jason Farmer | Jun 19, 2026 | Financial Oversight
The payment structure is published. The operating costs are not. Here is how to build a realistic dementia program profit and loss before you are a year in and surprised by the numbers. Key TakeawaysGUIDE base rates differ significantly by tier and by whether the...
by Jason Farmer | Jun 12, 2026 | Financial Oversight
An ownership stake in an ASC can be the most valuable asset in a gastroenterology group – or an eight-figure mistake. The difference is in the numbers you run before you sign. Key TakeawaysASC facility payments run roughly 52 to 58 percent of OPPS rates for GI...
by Jason Farmer | May 27, 2026 | Financial Oversight
Pathology, anesthesia, and infusion services can meaningfully improve GI practice economics. They can also generate federal enforcement exposure if the structure is wrong. The two outcomes depend on the same set of regulatory requirements. Key TakeawaysThe Stark Law...
by Jason Farmer | May 25, 2026 | Financial Oversight
The three most common ancillary lines in orthopedics each follow a different financial logic, a different compliance framework, and a different readiness threshold. Here is how to think through all three before you commit capital. Key TakeawaysIn-office imaging,...
by Jason Farmer | May 23, 2026 | Financial Oversight
Medicare has covered intensive behavioral therapy for obesity since 2012. Research found only 1.2 percent of eligible primary care providers ever billed it. That gap is the whole decision in miniature. Key TakeawaysMedicare’s IBT for obesity benefit covers up to...
